Systemic Rho-kinase inhibitor belumosudil for treatment of ocular graft versus host disease.

چکیده

We aimed to describe the response of chronic ocular graft versus host disease (oGVHD) to systemic belumosudil. A total of seven patients were included. Five patients underwent allogeneic stem cell transplant and two patients received allogeneic peripheral blood stem cell transplant. After starting…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• قرنیه